Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
weight loss
Biotech
Lilly's next focus: Testing incretins in neuro, immunology fields
“We'll be prepared to move rapidly into phase 3 trials based on clinical data and where our conviction is high,” Lilly's CSO Daniel Skovronsky said.
Gabrielle Masson
Feb 6, 2025 2:35pm
Versant launches another obesity biotech with $65M series A
Jan 28, 2025 8:35am
Veru's drug retains muscle mass for older patients taking Wegovy
Jan 27, 2025 8:14am
Obesity biotech Aardvark eyes IPO as Ascentage makes $126M debut
Jan 24, 2025 5:02am
Macrocyclic peptides preserve muscle in mice given semaglutide
Dec 12, 2024 12:45pm
BioAge obesity study derailed by side effects 2 months after IPO
Dec 9, 2024 4:36am